Effect of sodium thiosulfate on cisplatin removal with complete hepatic venous isolation and extracorporeal charcoal hemoperfusion: A pharmacokinetic evaluation

Annals of Surgical Oncology

Volumn 8, Issue 5, 2001, Pages 449-457

  Kusunoki, Nobuya ^a   Ku, Yonson ^a   Tominaga, Masahiro ^a   Iwasaki, Takeshi ^a   Fukumoto, Takumi ^a   Muramatsu, Sanshiro ^a   Sugimoto, Takemi ^a   Tsuchida, Shinobu ^a   Takamatsu, Manabu ^a   Suzuki, Yasuyuki ^a   Kuroda, Yoshikazu ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Cisplatin; Hepatic arterial infusion; Isolated hepatic chemoperfusion; Sodium thiosulfate

Indexed keywords

CHARCOAL; CISPLATIN; SODIUM THIOSULFATE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CANCER CHEMOTHERAPY; CAROTID ARTERY; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG MEGADOSE; EXTRACORPOREAL CIRCULATION; FEMALE; HEMOPERFUSION; HEPATIC ARTERY; MALE; NONHUMAN;

ANIMALS; CHARCOAL; CISPLATIN; DOGS; EXTRACORPOREAL CIRCULATION; FEMALE; HEMOPERFUSION; HEPATIC VEINS; MALE; SPECTROPHOTOMETRY, ATOMIC; THIOSULFATES; TIME FACTORS;

EID: 0034994820     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-001-0449-y     Document Type: Article

References (32)

1. Phase I-II trial of percutaneous intra-arterial cis-diamminedichloro platinum (II) for regionally confined malignancy
2. Clinical pharmacokinetics of intraarterial cisplatin in humans
3. Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies
4. Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases
5. Comparison of hepatic tissue extraction rates of cytotoxic anticancer drugs during hepatic arterial chemotherapy: Evaluation using direct hemoperfusion under hepatic venous isolation
6. Extracorporeal removal of anticancer drugs in hepatic artery infusion: The effect of direct hemoperfusion combined with veno-venous bypass
7. Extracorporeal cisplatin removal using direct hemoperfusion under hepatic venous isolation for hepatic arterial chemotherapy: An experimental study on pharmacokinetics
8. Clinical pilot study on high-dose intraarterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma
9. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: Evaluation with hepatic venous isolation and charcoal hemoperfusion
10. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors
11. Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion
12. Recent results of high-dose chemotherapy for advanced liver cancers with percutaneous isolated hepatic perfusion
13. Die therapie der peritonealkarzinose mit intraperitonealer gabe von cis-diaminodichloroplatin und systemischer natrium thiosulfat protektion
14. Interaction of cisplatin and carboplatin with sodium thiosulfate: Reaction rates and protein binding
15. Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin
16. Sodium thiosulfate disposition in humans: Relation to sodium nitroprusside toxicity
17. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry
18. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: Protective mechanism against cisplatin nephrotoxicity
19. High-performance liquid chromatographic analysis of unchanged cis-diamminedichloroplatinum (cisplatin) in plasma and urine with post-column derivatization
20. Reduction of systemic drug exposure after Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration: A feasibility study of a novel system
21. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors
22. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection
23. 'Two-route chemotherapy' using intra-arterial cisplatin and intravenous sodium thiosulfate, its neutralizing agent, for hepatic malignancies
24. Phased-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate
25. Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapy
26. Intraperitoneal cisplatin with systemic thiosulfate protection
27. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer
28. Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy - A phase II study of the EORTC gynaecological cancer cooperative group
29. Pharmacokinetics of cisplatin and the effect of sodium thiosulfate
30. Inactivation of cis-diamminedichloroplatinum (II) in blood and protection of its toxicity by sodium thiosulfate in rabbits
31. First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate
32. Protection of antiproliferative effect of cis-diamminedichloroplatinum (II) by sodium thiosulfate